baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Merrimack Pharmaceuticals Inc/ US5903282094 /

2024-05-08 10:00:00 PM	Chg. -0.0100	Volume	Bid10:00:24 PM	Ask10:00:24 PM	High	Low
15.0300USD	-0.07%	144,959 Turnover: 1.93 mill.	15.0200Bid Size: 300	15.0600Ask Size: 100	15.0600	15.0000

GlobeNewswire 04-08 TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H.,...

GlobeNewswire 02-15 OnKure Announces the Appointment of Samuel Agresta, M.D., as Chief Medical Officer

GlobeNewswire 02-07 Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franc...

GlobeNewswire 2023-10-24 Onconova Expands Leadership Team with Two Key Appointments

GlobeNewswire 2022-03-07 John Lunger, of Adaptimmune, Joins Genocea Biosciences' Board of Directors

GlobeNewswire 2021-06-15 William Sullivan, CPA, MBA joins Cytovia Therapeutics as Chief Financial Officer

GlobeNewswire 2021-05-28 180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeLuca MD, MBA t...

GlobeNewswire 2020-10-01 Elucida Oncology Appoints Dr. Eliel Bayever as Chief Medical Officer

GlobeNewswire 2020-08-03 Yumanity Therapeutics Appoints Ellen K. Forest as Chief Human Resources Officer

GlobeNewswire 2020-06-29 Aprea Therapeutics Appoints Fouad Namouni, M.D. and Richard Peters, M.D., Ph.D. to Board of Director...

GlobeNewswire 2019-12-09 Replimune Strengthens Executive Team with the Appointment of Jean Franchi as Chief Financial Officer

GlobeNewswire 2019-08-01 New Executive Team Announced at Adaptimmune

GlobeNewswire 2019-04-18 L Brands Announces Slate of Directors for 2019 Annual Meeting of Stockholders

GlobeNewswire 2019-04-18 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharma...

GlobeNewswire 2019-04-16 Report: Developing Opportunities within Eastman Chemical, Target, Federated Investors, First America...

GlobeNewswire 2019-04-12 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharm...

GlobeNewswire 2019-02-12 New Research: Key Drivers of Growth for ON Semiconductor, Entegris, Universal, MarineMax, Epizyme, a...

GlobeNewswire 2018-12-11 John M. Dineen Appointed to Syneos Health Board of Directors, Named Chairman

GlobeNewswire 2018-10-19 ADC Contract Manufacturing Market, 2030

GlobeNewswire 2018-09-21 Global Pancreatic Cancer Therapy Market Analysis and Forecasts 2017-2025 - Increase in Number of The...

GlobeNewswire 2018-08-16 Factors of Influence in 2018, Key Indicators and Opportunity within Celsion, Alpha and Omega Semicon...

GlobeNewswire 2018-06-22 Shire plc: Large-Scale European Review Suggests Disparity in Symptom Recognition and Standardized Tr...

GlobeNewswire 2018-05-30 What's Trending in Monoclonal Antibodies to 2022: Market by Structure [Chimeric, Humanized], Target ...

GlobeNewswire 2018-05-29 Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscie...

GlobeNewswire 2018-05-03 Outsourcing in Drug Discovery 2017-2018 & 2022 - Focus on the Contract Research Organization (CRO) M...

Merrimack Pharmaceuticals Inc/ US5903282094 /

If you wish to receive reply to your feedback, please provide your email address.